Fitch downgrades Merck; Scotland's NHS to cover Iclusig, Stivarga, others;

@FiercePharma: Valeant CEO's 2014 pay pales in comparison to new EVP's $50M-plus. Article | Follow @FiercePharma

@EricPFierce: ICYMI: Here's Baxter release on recall of 8 saline lots, 4 dextrose, 3 Lactated Ringer's Injection. Release | Follow @EricPFierce

> Fitch Ratings has downgraded Merck's ($MRK) rating to A from A+. Report (sub. req.)

> Branded to OTC switches represent huge market potential. More

> Scotland's NHS has accepted 7 new meds for use, including Bayer's Stivarga and Ariad's Iclusig. More

> Vectura says it intends to close its site in Gemünden, Germany. Report

Medical Device News

@FierceMedDev: GE VC arm will not be impacted by sale of GE Capital. Updated story | Follow @FierceMedDev

@VarunSaxena2: ICYMI from FierceDiagnostics: FDA announces LuSys Labs' recall of its unapproved Ebola diagnostic. Story | Follow @VarunSaxena2

@EmilyWFierce: Roche grabs CAPP Medical to gain ground in cancer Dx. FierceDiagnostics article | Follow @EmilyWFierce

> Medtronic-backed spinal imaging startup grabs $9.6M for back pain diagnostic to replace x-ray. Article

> Varian Medical Systems eyes Chinese market with potential Foxconn deal. Article

Biotech News

@FierceBiotech: ICYMI yesterday: After PhIII odyssey, the FDA finally gives Medicines Co a thumbs-up for cangrelor. Report | Follow @FierceBiotech

@JohnCFierce: Roche hustles its PD-L1 'breakthrough' star into 11 late-stage trials. News | Follow @JohnCFierce

> New data on GW Pharma's cannabis-based epilepsy drug stokes hopes of success. Report

> Incyte is opening an R&D command center in Geneva. Story

> Bayer hits the gas on its top cancer prospect with Phase III in sight. Article

Drug Delivery News

> J&J to use drug delivery device for HBV vaccine thanks to $85M partnership. Item

> 'BLAST' laser method allows large particle delivery to 100,000 cells per minute. Article

> KemPharm sets IPO price for up to $56 million. Report

> Israel's Intec discussing $150M drug delivery partnership with Big Pharma company. More

> Developer of surgically delivered microparticles to brain gets $72.5M in latest funding round. News

Pharma Manufacturing News

> Walgreens CEO hints at another supply chain deal. Item

> Actavis asks court to let it stop manufacturing older Alzheimer's treatment. Item

> Vectura will close plant in Germany within the year. Report

> Baxter again having to recall saline solution as shortage persists. Story

> Novo opens $100M plant in Russia. Article

Pharma Asia News

> IDT Australia release on FDA nod for 23 generics begs the question: Where's the beef? Story

> Australia's George Clinical eyes China drug discovery going global. More

> Takeda names U.S. head, bringing first woman to executive team. Report

> India moves partially on bar codes for exported drugs by July. Story

> TVM closes on $50M for China Biopharma plans. Article

And Finally... The FDA says some wrinkle creams may be overstating their claims. More

Suggested Articles

UnitedHealthcare will stop covering Descovy in PrEP in favor of Truvada, which is on track to see low-cost generic competition in September.

AstraZeneca has signed into the EU’s first finalized COVID-19 vaccine supply agreement.  

The U.K.'s two new deals with J&J and Novavax bring its stockpile of potential COVID-19 vaccines to 340 million doses while expanding clinical trials.